FASN and neoplasm: Tumor cells undergo lipid metabolic reprogramming through de novo lipogenesis involving key transcription factors such as sterol regulatory element binding protein (SREBP), ATP citrate lyase (ACLY), acetyl-CoA carboxylase (ACC), fatty acid synthase (FASN) and stearoyl-CoA desaturase 1 (SCD1).